全文获取类型
收费全文 | 16573篇 |
免费 | 990篇 |
国内免费 | 80篇 |
专业分类
耳鼻咽喉 | 132篇 |
儿科学 | 425篇 |
妇产科学 | 418篇 |
基础医学 | 2617篇 |
口腔科学 | 661篇 |
临床医学 | 1375篇 |
内科学 | 3664篇 |
皮肤病学 | 341篇 |
神经病学 | 1959篇 |
特种医学 | 450篇 |
外科学 | 1455篇 |
综合类 | 41篇 |
一般理论 | 5篇 |
预防医学 | 1012篇 |
眼科学 | 274篇 |
药学 | 1349篇 |
中国医学 | 57篇 |
肿瘤学 | 1408篇 |
出版年
2024年 | 18篇 |
2023年 | 171篇 |
2022年 | 393篇 |
2021年 | 591篇 |
2020年 | 360篇 |
2019年 | 477篇 |
2018年 | 574篇 |
2017年 | 451篇 |
2016年 | 522篇 |
2015年 | 649篇 |
2014年 | 738篇 |
2013年 | 936篇 |
2012年 | 1469篇 |
2011年 | 1563篇 |
2010年 | 775篇 |
2009年 | 741篇 |
2008年 | 1166篇 |
2007年 | 1087篇 |
2006年 | 1015篇 |
2005年 | 925篇 |
2004年 | 829篇 |
2003年 | 753篇 |
2002年 | 641篇 |
2001年 | 75篇 |
2000年 | 54篇 |
1999年 | 69篇 |
1998年 | 105篇 |
1997年 | 94篇 |
1996年 | 60篇 |
1995年 | 57篇 |
1994年 | 42篇 |
1993年 | 30篇 |
1992年 | 19篇 |
1991年 | 16篇 |
1990年 | 12篇 |
1989年 | 23篇 |
1988年 | 15篇 |
1987年 | 22篇 |
1986年 | 14篇 |
1985年 | 14篇 |
1984年 | 11篇 |
1983年 | 15篇 |
1982年 | 13篇 |
1981年 | 12篇 |
1980年 | 5篇 |
1979年 | 5篇 |
1978年 | 4篇 |
1975年 | 3篇 |
1973年 | 6篇 |
1961年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
7.
Peter Marhofer Malachy Columb Phil M. Hopkins Manfred Greher Daniela Marhofer Max R. Levi Bienzle Markus Zeitlinger 《British journal of anaesthesia》2019,122(4):525-531
Background
The efficacy of dexamethasone in extending the duration of local anaesthetic block is uncertain. In a randomised controlled triple blind crossover study in volunteers, we tested the hypothesis that neither i.v. nor perineurally administered dexamethasone prolongs the sensory block achieved with ropivacaine.Methods
Ultrasound-guided ulnar nerve blocks (ropivacaine 0.75% wt/vol, 3 ml, with saline 1 ml with or without dexamethasone 4 mg) were performed on three occasions in 24 male volunteers along with an i.v. injection of saline 1 ml with or without dexamethasone 4 mg. The combinations of saline and dexamethasone were as follows: control group, perineural and i.v. saline; perineural group, perineural dexamethasone and i.v. saline; i.v. group, perineural saline and i.v. dexamethasone. Sensory block was measured using a VAS in response to pinprick testing. The duration of sensory block was the primary outcome and time to onset of sensory block the secondary outcome.Results
All 24 subjects completed the trial. The median [inter-quartile range (IQR)] duration of sensory block was 6.87 (5.85–7.62) h in the control group, 7.37 (5.78–7.93) h in the perineural group and 7.37 (6.10–7.97) h in the i.v. group (P=0.61). There was also no significant difference in block onset time between the three groups.Conclusion
Dexamethasone 4 mg has no clinically relevant effect on the duration of sensory block provided by ropivacaine applied to the ulnar nerve.Clinical trial registration
DRKS, 00014604; EudraCT, 2018-001221-98. 相似文献8.
9.
10.
Caterina Proto Daniela Romualdi Rosa Maria Cento Rosario S Spada Giuseppina Di Mento Raffaele Ferri Antonio Lanzone 《Gynecological endocrinology》2006,22(4):213-218
BACKGROUND: In the central nervous system, several neuropeptides are believed to be involved in the pathophysiology of Alzheimer's disease (AD). Indeed, previous studies have documented that glucagon-like peptide 1 (GLP-1) possesses neurotropic properties and can reduce amyloid-beta peptide levels in the brain in vivo. Moreover, the concentrations of neuropeptide Y (NPY) seem to be altered in the cerebrospinal fluid of patients with AD and in subjects with major depression. Finally, among the modifications induced by aging, a dysregulation of the ghrelin-growth hormone (GH) system has been reported. METHODS: We investigated the plasma concentrations of these neuropeptides in 14 subjects with AD. Data obtained from these patients were compared with data from an age- and weight-matched healthy group. RESULTS: No significant differences were found between the two groups in relation to plasma levels of GLP-1, NPY, ghrelin and GH. Peripheral NPY concentrations were positively correlated with ghrelin levels in both groups, and with plasma GLP-1 concentration only in controls. CONCLUSION: On the basis of our results, peripheral levels of these neuropeptides seem not to serve as biochemical markers of AD. 相似文献